ArticleIn silico pharmacology2025

Targeting SARS-CoV-2 variants with Bromelain: an in-silico study of Spike-ACE2 inhibition using docking, molecular dynamic simulation, and MM-PBSA.

Palash Ahuja et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.